Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01838356 · ClinicalTrials.gov registry record
Intracranial Atherosclerosis and Depression After Coronary Artery Bypass Graft
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 169
- Enrollment target
NCT01838356: Completed study, sponsored by Yale University.
NCT01838356 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 169 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01838356 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 169 participants
- Enrollment target
Study Summary
The purpose of the study is to examine if blood flow in the brain before coronary artery bypass graft surgery has an effect on depression after surgery. The main hypothesis of the study states that pre-surgical blood flow in the brain will be an independent risk factor for depression after surgery after adjusting for other risk factors such as gender, pre-CABG depression, social support, medical comorbidity burden, socioeconomic status, and neuroticism.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 169 participants |
| Start Date | 2012-09 |
What the finished NCT01838356 record still lists
NCT01838356 is an observational study that tracks outcomes without assigning an intervention. The registered 169 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01838356 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01838356 about?
NCT01838356 is a clinical study titled "Intracranial Atherosclerosis and Depression After Coronary Artery Bypass Graft". The purpose of the study is to examine if blood flow in the brain before coronary artery bypass graft surgery has an effect on depression after surgery. The main hypothesis of the study states that pre-surgical blood flow in the brain will be an independent risk factor for depression after surgery ...
What is the current status of trial NCT01838356?
This trial is currently completed. The enrollment target is 169 participants. The study started on 2012-09.
Who is sponsoring clinical trial NCT01838356?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06191484 · 169 participants · NA
Risk and Resilience to Suicide Following Late-Life Spousal Bereavement
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia